Cerebral malaria

Handbook of Clinical Neurology

Volumn 114, Issue , 2013, Pages 91-102

  Postels, Douglas G ^a   Birbeck, Gretchen L ^a,b,c  

^a East Lansing   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Chikankata Hospital   (Zambia)

Author keywords

Coma; Intracranial pressure; Pathophysiology; Retinopathy; Sequelae

Indexed keywords

EID: 84879863152     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53490-3.00006-6     Document Type: Chapter

References (83)

1. Alonso P.L., Lindsay S.W., Armstrong J.R., et al. The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet 1991, 337:1499-1502.
2. Anstey N.M., Weinberg J.B., Hassanali M.Y., et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996, 184:557-567.
3. Aursudkij B., Wilairatana P., Vannaphan S., et al. Pulmonary edema in cerebral malaria patients in Thailand. Southeast Asian J Trop Med Public Health 1998, 29:541-545.
4. Bangirana P., Musisi Seggane P., Allebeck B., et al. A preliminary examination of the construct validity of the KABC-II in Ugandan children with a history of cerebral malaria. Afr Health Sci 2009, 9:186-192.
5. Beare N.A., Southern C., Chalira C., et al. Prognostic significance and course of retinopathy in children with severe malaria. Arch Ophthalmol 2004, 122:1141-1147.
6. Beare N.A., Taylor T.E., Harding S.P., et al. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 2006, 75:790-797.
7. Berendt A.R., Simmons D.L., Tansey J., et al. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989, 341:57-59.
8. Birbeck G.L., Molyneux M.E., Kaplan P.W., et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010, 9:1173-1181.
9. Briand V., Cottrell G., Massougbodji A., et al. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J 2007, 6:160.
10. Brown H., Turner G., Rogerson S., et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis 1999, 180:1742-1746.
11. Brown H.C., Chau T.T., Mai N.T., et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology 2000, 55:104-111.
12. Brown H., Rogerson S., Taylor T., et al. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg 2001, 64:207-213.
13. Clark I.A. Along a TNF-paved road from dead parasites in red cells to cerebral malaria, and beyond. Parasitology 2009, 136:1457-1468.
14. Clark I.A., Rockett K.A., Cowden W.B. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992, 340:894-896.
15. Clark I.A., Awburn M.M., Whitten R.O., et al. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar J 2003, 2:6.
16. Cranston H.A., Boylan C.W., Carroll G.L., et al. Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science 1984, 223:400-403.
17. Crawley J., Smith S., Kirkham F., et al. Seizures and status epilepticus in childhood cerebral malaria. QJM 1996, 89:591-597.
18. Crawley J., Waruiru C., Mithwani S., et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet 2000, 355:701-706.
19. Crawley J., Smith S., Muthinji P., et al. Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child 2001, 84:247-253.
20. Dondorp A.M., Fanello C.I., Hendriksen I.C., et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010, 376:1647-1657.
21. Dondorp A.M., Kager P.A., Vreeken J., et al. Abnormal blood flow and red blood cell deformability in severe malaria. Parasitol Today 2000, 16:228-232.
22. Dondorp A., Nosten F., Stepniewska K., et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005, 366:717-725.
23. Dondorp A.M., Lee S.J., Faiz M.A., et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008, 47:151-157.
24. Dondorp A.M., Nosten F., Yi P., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
25. Enwere G. A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria. Trop Med Int Health 2005, 10:1171-1175.
26. Enwere G., Van Hensbroek M.B., Adegbola R., et al. Bacteraemia in cerebral malaria. Ann Trop Paediatr 1998, 18:275-278.
27. Ginsburg H., Famin O., Zhang J., et al. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 1998, 56:1305-1313.
28. Global Health Group and the Malaria Atlas Project Atlas of Malaria-Eliminating Countries, 2011 2011, The Global Health Group, Global Health Sciences, University of California, San Francisco, San Francisco.
29. Glover S.J., Maude R.J., Taylor T.E., et al. Malarial retinopathy and fluorescein angiography findings in a Malawian child with cerebral malaria. Lancet Infect Dis 2010, 10:440.
30. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. Am J Trop Med Hyg 2004, 70:1-7.
31. Greenwood B.M., Greenwood A.M., Bradley A.K., et al. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet 1988, 1:1121-1127.
32. Hemmer C.J., Kern P., Holst F.G., et al. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am J Trop Med Hyg 1991, 45:608-612.
33. Hess K.M., Goad J.A., Arguin P.M., et al. Intravenous artesunate for the treatment of severe malaria. Ann Pharmacother 2010, 44:1250-1258.
34. Holding P.A., Stevenson J., Peshu N., et al. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 1999, 93:529-534.
35. Idro R., Jenkins N.E., Newton C.R. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005, 4:827-840.
36. Jones K.L., Donegan S., Lalloo D.G. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev 2007, 4. CD005967.
37. Kobbe R., Kreuzberg C., Adjei S., et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007, 45:16-25.
38. Kochar D.K., Shubhakaran B., Kumawat L., et al. Cerebral malaria in Indian adults: a prospective study of 441 patients from Bikaner, north-west India. J Assoc Physicians India 2002, 50:234-241.
39. Krishna S., Waller D.W., ter Kuile F., et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg 1994, 88:67-73.
40. Kyu H.H., Fernandez E. Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review. Bull World Health Organ 2009, 87:896-904.
41. Leder K., Black J., O'Brien D., et al. Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis 2004, 39:1104-1112.
42. Leech J.H., Barnwell J.W., Miller L.H., et al. Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes. J Exp Med 1984, 159:1567-1575.
43. Lewallen S., Wills B.A. Retinal haemorrhage in children with malaria. Lancet 1993, 341:442.
44. Lewallen S., Bronzan R.N., Beare N.A., et al. Using malarial retinopathy to improve the classification of children with cerebral malaria. Trans R Soc Trop Med Hyg 2008, 102:1089-1094.
45. Lindsay S.W., Gibson M.E. Bednets revisited: old idea, new angle. Parasitol Today 1988, 4:270-272.
46. Looareesuwan S., Warrell D.A., White N.J., et al. Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Med Hyg 1983, 32:911-915.
47. Looareesuwan S., Warrell D.A., White N.J., et al. Do patients with cerebral malaria have cerebral oedema? A computed tomography study. Lancet 1983, 1:434-437.
48. Lyke K.E., Burges R., Cissoko Y., et al. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 2004, 72:5630-5637.
49. Markley J.D., Edmond M.B. Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med 2009, 16:424-430.
50. Menendez C., Todd J., Alonso P.L., et al. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. J Trop Med Hyg 1994, 97:244-248.
51. Milner D.A. Rethinking cerebral malaria pathology. Curr Opin Infect Dis 2010, 23:456-463.
52. Mohanty S., Patel D.K., Pati S.S., et al. Adjuvant therapy in cerebral malaria. Indian J Med Res 2006, 124:245-260.
53. Mohsen A.H., McKendrick M.W., Schmid M.L., et al. Postmalaria neurological syndrome: a case of acute disseminated encephalomyelitis?. J Neurol Neurosurg Psychiatry 2000, 68:388-389.
54. Molyneux M.E., Taylor T.E., Wirima J.J., et al. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989, 71:441-459.
55. Muentener P., Schlagenhauf P., Steffen R. Imported malaria (1985-95): trends and perspectives. Bull World Health Organ 1999, 77:560-566.
56. Newton C.R., Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998, 79:1-53.
57. Newton C.R., Warrell D.A. Neurological manifestations of falciparum malaria. Ann Neurol 1998, 43:695-702.
58. Newton C.R., Hien T.T., White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 2000, 69:433-441.
59. Nguyen T.H., Day N.P., Ly V.C., et al. Post-malaria neurological syndrome. Lancet 1996, 348:917-921.
60. O'Meara W.P., Bejon P., Mwangi T.W., et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008, 372:1555-1562.
61. Ogutu B.R., Newton C.R., Muchohi S.N., et al. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus. Br J Clin Pharmacol 2003, 56:112-119.
62. Okiro E.A., Al-Taiar A., Reyburn H., et al. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J 2009, 8:4.
63. Pagola S., Stephens P.W., Bohle D.S., et al. The structure of malaria pigment beta-haematin. Nature 2000, 404:307-310.
64. Patankar T.F., Karnad D.R., Shetty P.G., et al. Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings. Radiology 2002, 224:811-816.
65. Phu N.H., Hien T.T., Mai N.T., et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002, 347:895-902.
66. Potchen M.J., Birbeck G.L., Demarco J.K., et al. Neuroimaging findings in children with retinopathy-confirmed cerebral malaria. Eur J Radiol 2010, 74:262-268.
67. Price R.N., Tjitra E., Guerra C.A., et al. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77:79-87.
68. Rao A., Kumar M.K., Joseph T., et al. Cerebral malaria: insights from host-parasite protein-protein interactions. Malar J 2010, 9:155.
69. Reyburn H., Mbatia R., Drakeley C., et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005, 293:1461-1470.
70. Roca-Feltrer A., Carneiro I., Smith L., et al. The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings. Malar J 2010, 9:282.
71. Rockett K.A., Awburn M.M., Aggarwal B.B., et al. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun 1992, 60:3725-3730.
72. Sein K.K., Maeno Y., Thuc H.V., et al. Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg 1993, 48:504-511.
73. Senanayake N. Delayed cerebellar ataxia: a new complication of falciparum malaria?. Br Med J (Clin Res Ed) 1987, 294:1253-1254.
74. Silamut K., Phu N.H., Whitty C., et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 1999, 155:395-410.
75. Snow R.W., Guerra C.A., Noor A.M., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
76. Taylor T.E., Fu W.J., Carr R.A., et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004, 10:143-145.
77. Trape J.F., Rogier C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 1996, 12:236-240.
78. Turner G.D., Morrison H., Jones M., et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994, 145:1057-1069.
79. van der Heyde H.C., Nolan J., Combes V., et al. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006, 22:503-508.
80. van Hensbroek M.B., Palmer A., Jaffar S., et al. Residual neurologic sequelae after childhood cerebral malaria. J Pediatr 1997, 131:125-129.
81. Vyas S., Gupta V., Hondappanavar A., et al. Magnetic resonance imaging of cerebral malaria. J Emerg Med 2010, 42:e117-119.
82. World Health Organization Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000, 94:S1-S90.
83. Zougbede S., Miller F., Ravassard P., et al. Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity. J Cereb Blood Flow Metab 2011.